The Rundown: ExL’s Blog
Viewing 41 to 50 of 127 records.
BROCHURE AVAILABLE: Central Monitoring Summit
Wednesday January 17th, 2018
We invite you to download the brochure for ExL Events’ Central Monitoring Summit, taking place on March 22–23 in Philadelphia. Now that you’ve implemented risk-based monitoring or are thinking about it, what happens next? Our expert speaking faculty will be discussing what quantitative data has been found through RBM and how to optimize efforts moving toward a more centralized monitoring system.
Meet several of our experienced speakers
Lisa Berdan, Director Global Megatrials, DUKE CLINICAL RESEARCH INSTITUTE
Kimberly Nessel, Director, Clinical Scientist CVM, JANSSEN R&D
Anne M. Smith, Consultant, Central Monitoring, ELI LILLY AND COMPANY
David Bocobo, Senior Central Monitor — Risk-Based Monitoring, BRISTOL-MYERS SQUIBB
Sina Djali, Senior Director, THE JANSSEN PHARMACEUTICAL COMPANIES OF JOHNSON…
From the Creators of Digital Pharma: The Disease Awareness Campaigns Forum
Tuesday January 16th, 2018
Disease awareness campaigns have long been used by the industry to disseminate unbranded, educational information about the burden of a disease state. Before launching educational campaigns, all team members should understand how to educate their audience about a condition outside of a clinical setting, in a way that is meaningful and relevant.
The Disease Awareness Campaigns Forum, taking place April 4–5, 2018 in Philadelphia, is the industry’s only conference dedicated to the strategies for bundling educational campaigns that resonate with both patient providers. Join us to learn how to better refine patient and physician education strategies…
Join Us at the Pharmacovigilance Audit and Inspections Conference
Monday January 15th, 2018
ExL Events invites you to download the brochure for the Pharmacovigilance Audit and Inspections Conference taking place on March 26–27 in Philadelphia.
The Pharmacovigilance Audit and Inspections Conference will illustrate how leaders in the pharmaceutical industry are creating risk management plans, utilizing the latest innovative methods and technologies to effectively prepare and improve their audit and inspection processes. Leading industry executives will discuss the newly released GVP guidelines and the latest technologies that can be used to improve your organization’s performance and reporting.
CASE STUDY: Pharmacovigilance Exchange Through Pfizer’s PvX
Boris Videlov, Head…
Medical Marijuana Update Ahead of the Cannabis Partnerships Congress
Monday January 15th, 2018
A new article published by the Chicago Tribune addresses the state of medical marijuana in Illinois, which we’d like to share with you. Ahead of our inaugural Cannabis Partnerships Congress (March 12–13 in San Francisco), there’s plenty of news and updates coming in all around the country that will surely be addressed by our expert speaking faculty. Find out more below!
Highlights from this article include:
The number of patients allowed to buy the drug is still too low for some operators to recoup investments. That is…
Unskippable Snapchat Ads, Pharma, and the 2018 FiercePharmaMarketing Forum
Thursday January 11th, 2018
While mixing tech with pharma isn’t exactly a new concept, you might be surprised to learn that Snapchat could be a vital partner for the industry. Join us at the 2018 FiercePharmaMarketing Forum (March 6–7 in New York City) to learn (among many other things) just how this popular smartphone app’s new advertising platform can benefit pharma and those working in related fields.
According to FiercePharma, Doug Weinbrenner, VP of engagement strategy at FCB Health’s Area 23, recently revealed…
Understanding the Patient’s Journey at the Disease Awareness Campaigns Forum
Tuesday January 9th, 2018
An effective disease awareness campaign requires a deep understanding of the patient’s journey. Understanding how patients and healthcare professionals communicate about a disease state is crucial to develop educational and informative messaging for a campaign. To inform disease state knowledge gaps, it is also vital that healthcare professionals have the latest, most accurate information available regarding a disease state, and understand how to speak with their patients about this data.
The Disease Awareness Campaigns Forum, taking place April 4–5, 2018 in Philadelphia, is the industry’s only event dedicated to strategies for building educational disease awareness…
Artificial Intelligence and Stem Cell Research at the Medical Imaging in Clinical Research Event!
Monday January 8th, 2018
At the Medical Imaging in Clinical Research conference, convening February 12–13 in San Francisco, senior-level executives from academia, pharma, biotechs, and medical device companies will explore how they are incorporating an innovative imaging strategy into their trial research to improve standardization and treatment.
We are excited to announce two new-featured sessions:
Artificial Intelligence in Medical Imaging: How to See the Unknown
Dr. Christopher R. Hancock, Director of Neuroradiology, BLUE SKY RADIOLOGY
CASE STUDY: Fluorescent and Imaging Markers on Cells for the Demonstration of Lateral Epigenetic Shifting
Timothy Ganey, Chief Scientific Officer, VIVEX BIOMEDICAL,…
Final Week — Early Bird Pricing Expiring for Medicare Conference 2018!
Monday January 8th, 2018
There’s still time to reserve your seat and get the best pricing for ExL Events’ Medicare Conference 2018 (February 26–27, Austin) — but hurry, this exclusive rate will expire Friday, January 12! Join John Gorman, Founder of GORMAN HEALTH GROUP, and 20 more health plan and health system executives from our esteemed speaking faculty! Discuss the implications of value-based arrangements for traditional employer groups, government programs and public exchanges through our many networking opportunities!
H. Scott Sarran, M.D., M.M., Senior…
Advances in Drug Delivery Seminar in Boston!
Thursday January 4th, 2018
In its seventh year, ExL’s Drug Formulation, Solubility & Bioavailability Summit (March 26–28, 2018, Boston) offers an exclusive, full-day seminar on Advances in Drug Delivery.
Advances in Drug Delivery Seminar Topics
Maintain Necessary Flexibility in the Clinical Testing and Production of Solid Dosage Tablets
Joachim Hoechel, Head, Clinical Pharmacology, BAYER
Panel: Achieve Breakthroughs in Oral Biologics Delivery
Moderator: Rakesh Dixit, Vice President, R&D, Global Head Biologics Safety Assessment, MEDIMMUNE
Encapsulation and Release of Peptides and Biologics at Higher Loadings Than W/O/W…
AstraZeneca, Pfizer, Vifor Pharma and More Help Map Out the Best Action Plan for Your Next M&A and Partnering Deal!
Monday December 18th, 2017
At the European Due Diligence Summit for Life Sciences, being held 26–27 February in London, attendees will gain valuable insights from key decision-makers, investors, business development, licensing and alliance management experts from across the pharmaceutical and biotechnology industries. Engage with your peers in a unique learning format consisting of multiple panel discussions and never-before-heard case studies and discover best practices on both buy-side and sell-side transactions from due diligence leaders.
Sessions Built to Address the Challenges of M&A, Licensing and Partnering Deals:
Virtual Due Diligence and How to…
From The Blog
- Commercial Strategy
- Content Marketing
- Data Management
- Digital Marketing
- Drug Safety
- Emerging Markets
- ExL Events News
- Medical Devices
- Medical Education
- Meeting Planning
- Patient Engagement
- Public/Government Relations
- Regulatory Affairs